Enzon's Oncaspar
Executive Summary
Price listed as $1,225 per 750 iu/ml in 5 ml vials in the April 1994 Red Book. Oncaspar (pegaspargase) was approved Feb. 1 for acute lymphoblastic leukemia patients who require L-asparaginase treatment for ALL but have developed hypersensitivity to the native forms of L-asparaginase ("The Pink Sheet" Feb. 7, T&G-1)